These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34743574)

  • 41. Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series.
    Pasvolsky O; Zoref-Lorenz A; Abadi U; Geiger KR; Hayman L; Vaxman I; Raanani P; Leader A
    Int J Hematol; 2019 May; 109(5):553-562. PubMed ID: 30850926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a systematic review and meta analysis.
    Qin Q; Xie Z; Shen Y; Yang S; Liu C; Huang Z; Xu J; Al J; Shen K
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):672-8. PubMed ID: 22774410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of Hematopoietic Stem Cell Transplantation in Treatment of Hemophagocytic Lymphohistiocytosis.
    Nikiforow S
    Hematol Oncol Clin North Am; 2015 Oct; 29(5):943-59. PubMed ID: 26461153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation.
    Baek DW; Moon JH; Lee JH; Kang KW; Lee HS; Eom HS; Lee E; Lee JH; Lee JO; Park SK; Kim SJ; Yoo KH; Yoon SS; Koh Y; Kang HJ; Won JH; Lyu CJ; Hahn SM; Lee JH; Park JS; Jo JC; Mun YC; Yang DH; Song GY; Lim SN; Sohn SK;
    Blood Cancer J; 2023 Jun; 13(1):95. PubMed ID: 37365207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.
    Zhao A; Yang J; Li M; Li L; Gan X; Wang J; Li H; Shen K; Yang Y; Niu T
    Front Immunol; 2022; 13():882589. PubMed ID: 35479073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of allogeneic hematopoietic stem cell transplantation for primary hemophagocytic lymphohistiocytosis in adults.
    He L; Wang Y; Suolitiken D; Zhang R; Liu M; Hua Z; Yao S; Zou H; Wang Z
    Hematol Oncol; 2022 Aug; 40(3):390-399. PubMed ID: 35526261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
    Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
    Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis.
    Wang J; Duan X; Yang L; Liu X; Hao C; Dong H; Gu H; Tang H; Dong B; Zhang T; Gao G; Liang R
    Cell Transplant; 2020; 29():963689720975397. PubMed ID: 33238731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic Factors and Outcomes in Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-center Experience.
    Apodaca E; Rodríguez-Rodríguez S; Tuna-Aguilar EJ; Demichelis-Gómez R
    Clin Lymphoma Myeloma Leuk; 2018 Oct; 18(10):e373-e380. PubMed ID: 30037588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults.
    Hattori N; Sato M; Uesugi Y; Nakata A; Sasaki Y; Shimada S; Watanuki M; Fujiwara S; Kawaguchi Y; Arai N; Uto Y; Matsui T; Yanagisawa K; Tahara S; Koeffler HP; Iezumi K; Nakamaki T
    Int J Hematol; 2021 May; 113(5):693-702. PubMed ID: 33385294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemophagocytic lymphohistiocytosis: a rare complication of autologous stem cell transplantation.
    ColiŢă A; ColiŢă A; Dobrea CM; Tănase AD; Şaguna C; Ghimici CG; Manolache RM; Angelescu S; Barbu D; Grădinaru F; Lupu AR
    Rom J Morphol Embryol; 2016; 57(2):551-7. PubMed ID: 27516033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
    El-Cheikh J; Crocchiolo R; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Lemarie C; De Colella JM; Granata A; Coso D; Bouabdallah R; Chabannon C; Blaise D
    Am J Hematol; 2013 May; 88(5):370-4. PubMed ID: 23460414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens.
    Schechter T; Naqvi A; Weitzman S
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1101-6. PubMed ID: 24871821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome.
    Tsuji T; Hirano T; Yamasaki H; Tsuji M; Tsuda H
    Ann Hematol; 2014 May; 93(5):821-6. PubMed ID: 24705932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Research Progress of Allogeneic Hematopoietic Stem Sell Trans-plantation in the Treatment of Adult Hemophagocytic Lympho-histiocytosis --Review].
    Tu ST; Zhou YL; Li F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):301-305. PubMed ID: 36765516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis.
    Hamidieh AA; Pourpak Z; Hashemi S; Yari K; Fazlollahi MR; Movahedi M; Behfar M; Moin M; Ghavamzadeh A
    Eur J Haematol; 2014 Apr; 92(4):331-6. PubMed ID: 24330187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan.
    Yanagisawa R; Nakazawa Y; Matsuda K; Yasumi T; Kanegane H; Ohga S; Morimoto A; Hashii Y; Imaizumi M; Okamoto Y; Saito AM; Horibe K; Ishii E;
    Int J Hematol; 2019 Feb; 109(2):206-213. PubMed ID: 30535855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Li Z; Wang Y; Wang J; Zhang J; Wang Z
    Leuk Lymphoma; 2018 Jan; 59(1):77-84. PubMed ID: 28573910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant.
    Elshenawy MA; Shahzad Rauf M; Elhassan TAM; Maghfoor I; Akhtar S
    Ann Hematol; 2018 Jul; 97(7):1229-1240. PubMed ID: 29484455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.